Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ma probably paved the way to the groundbreaking Partex partnerships of which will come very little of any benefit unless and until Anavex get a drug to market. To date no regulator has received a marketing authorisation application to look at in its full glory of endless pages upon pages.
it was just BSIG blowing up another load of dry powder. Short lived, but looked good as long as it lasted.
Any figures on people with Asperger's? I am absolutely certain that will be another indication in the pipeline soon. If not with A2-73, then A3-71 or some other Anavex compound.
Exactly! When Missling says Anavex trials and results are blinded, what he really means is that retail investors are being bamboozled into believing readouts are fine even when they are not. Then he keeps promising all sorts of stuff that doesn't happen, while calling it catalysts. After more that 5 years of that many still fall for it.
Let's see Anavex actually filing for approval before worrying about all sorts of at this point immaterial concerns.
What did you have for lunch?
The KEM Formal Concept Analysis is a very specific application of AI mixed with discrete statistics and data analysis.
AI is many things, but the media is not good at explaining the concepts involved and so a lot of people think of AI as magic or even terrifying.
Much more similar than WGT bias allows to contemplate. What was the n of the odds ratios Anavex resorted to report for their P2b/3 readout? Whatever that n was, it represents a subgroup of patients and is an outcome measure that deviates from the expected per protocol outcome measures.
About a furlong.
True of the active drug too. But one difference is that placebo may not affect biomarkers in the same way as the active drug for those given that.
Annovis straight up recognises that a pivotal PIII trial is required!
Anavex or somebody should market the best ever placebo pill, the effect is real and has only imaginary side effects.
It is amazing how the mind can state influence the health of the rest of the body.
It’s a shame the placebo effect can’t be patented, but someone could claim new and effective methods of inducing it.
Were any of the CEOs you advised members of the upper echelons of biotech investors?
Barons doesn’t know more than the rest of us. Based their 12 months $AVXL forecast the MAA filing and validation feels like $40 in their analysis, which would be fine.
Will it happen? We wait to see…
News is always on the way, and
Yes probably more digestible and easy to comprehend a furlong at a time in less than a fortnight.
Probably not, but I would recommend this wonderful rendition of the story:
There is precious little of what you post that is a must see, most is a best ignore!
Missling opened up for the possibility that the P2b/3 full data presentation could happen prior to and independent of a published peer reviewed article. One interpretation of that could be that a journal is taking an indefinite time process the peer review and publishing, or it has been declined. Another could be that the data presentation is coinciding with something yet to be revealed e.g. MAA submission, a scientific conference or any other wonderfulness.
Yes wait until just after 13th May that little problem might not consume to whole ASM.
85% chance.
Nope we write the script, always steps ahead you!
lol! It’s a bit like the Irish joke about asking directions - if that’s where you want to go, I wouldn’t have started here.
Or sideways!
Read my reply to Xena's post.
Yes Anavex did not met all endpoints as defined at the time of their Dec 22 fumbled topline presentation, when Anavex claimed they were met. That was always clear and is now established by Missling himself recently admitting that ADL was not significant.
Since then alternative ways of presenting the data from the P2b/3 have been used and may indeed be approvable. The EMA submission if/when finalised, submitted and validated may then in turn lead to approval. That outcome will not be known for another year or so.
Spend sometime thinking about it. It could help you become a better biotech investor or just in general investing in public listed companies based required information disclosures.
Only if as an investor in a public company you can rely on public information that the company is responsible for updating, such as that on clinicaltrials.gov and in their presentations.
It was and is lying to state all endpoints were met. A strange thing to say, when also at the same time saying they did't have all the data in until last minute. It was clear all along to experienced biotech investors that ADL was not stat sig.
It is rare I sell and even rarer that buy $AVXL. Each time aiming to improve my risk/reward and all the time being way in profit from selling at every irrational price spike with zero FOMO concerns. If something absolutely great should happen, I can always buy in with lower risk, but for a for smaller gain. I have no need to increase risk without a higher chance of a return.
What anyone might or might not do inspired by anything I post, is their own issue. I am not an investment advisor to anyone here. I don't care whether folks posting here owns $AVXL or not.
I never look in the rear mirror and think if only, cause its a useless waste of energy. I do however try to learn from my mistakes and of course the wonderful insights posted here.
Probably tomorrow will be worse. But but but there is an 85% WGT chance so what could possibly go wrong?
Bought some at the unpredicted LOD. I reckon the other side of index rebalancing will make that bit of dry power dryer.
Bas, you may use this advise and shared it with BSIG or was that just Sparky's thing?
Usually the saying goes, no news is good news. I guess it is becoming, old news is good news! We certainly don't want more new news at this rate.
I have found the same works with the Flying Spaghetti Monster - it is rocking my world, I think but I don't really know and it doesn't matter that much for anything anyway. Do you think maybe the FDA will listen to The Flying Spaghetti Monster? - who knows maybe, cool in'it!
Presumably you believe that is the reason you have not become hugely rich yet?
Must been bas deploying more dry powder.
And we know who it wasn't.
Oh oh! Did Missling speak again somewhere?
You have said that so many times.